A job reviewing drug applications at the Food and Drug Administration can be the springboard for a career in industry. Andrew Harnik/AP hide caption
Pharmaceuticals : Shots - Health News Pharmaceuticals
Duchenne muscular dystrophy patients Jack Willis (center), Nolan Willis (right) and Max LeClaire, attended the opening of Sarepta Therapeutics new headquarters in Cambridge, Mass., in 2014. Boston Globe via Getty Images hide caption
Controversy Continues Over Muscular Dystrophy Drug, Despite FDA Approval
How big a deal is the spending on drugs for rare diseases? Mark Airs/Ikon Images/Getty Images hide caption
Where are the generic alternatives to EpiPen and other expensive drugs that have lost patent protection? Victor J. Blue/Bloomberg via Getty Images hide caption
Experimental drugs that clear clumps of proteins from the brains of Alzheimer's patients haven't panned out yet. Science Photo Library/Pasieka/Getty Images hide caption
Test Of Experimental Alzheimer's Drug Finds Progress Against Brain Plaques
Mylan, the maker of EpiPen, says it will sell a generic version for $300 for a two-pack, a price that consumer advocates say is still too high. The device is used to treat severe allergic reactions. Daniel Acker/Bloomberg via Getty Images hide caption
In states that made medical marijuana legal, prescriptions for a range of drugs covered by Medicare dropped. Chris Hondros/Getty Images hide caption
A single modest meal for a doctor was associated with a higher likelihood he or she would prescribe Crestor, a cholesterol drug, instead of a generic. Daniel Acker/Bloomberg via Getty Images hide caption
A federal judge has agreed to end a trial of FedEx which started Monday in San Francisco. The firm had been accused of shipping packages from illegal online pharmacies. Prosecutors did not specify why they abruptly moved to drop the case. Seth Perlman/AP hide caption
What if a drug could knock out Staphylococcus aureus bacteria like these without disturbing the bacteria that help make you healthy? NIAID/Flickr hide caption
This prototype built by MIT researchers can be reconfigured to manufacture different types of pharmaceuticals. Courtesy of the Allan Myerson lab hide caption
Putting experimental drugs to the test can be a way of life. Glow Wellness/Glow RM/Getty Images hide caption
Stephane Schubhan, one of six men hospitalized after the clinical trial, still suffers from neurological damage. Jean-Francois Monier/AFP/Getty Images hide caption
A white board showed the drugs in short supply at the University of Utah Hospital in Salt Lake City in 2011. Jim Urquhart/AP hide caption